Today, a COVID-19 Regional Infusion Center offering the monoclonal antibody treatment Regeneron – COV (Casirivimab plus Imdevimab) opened in Fort Worth. According to the Infusion Center Info Sheet, “[t]his site will accept patient referrals from healthcare providers across TSAs C, D, and E to help administer COVID therapeutics quickly and safely with the goal of preventing patients from needing hospitalization.”
Referrals are required for treatment. To see if your patients qualifies, check the North Central Texas COVID-19 Regional Infusion Info Sheet. If they are eligible, you can complete the referral by filling out this form and sending in in by fax (210-208-5295) or email (InfusionReferral@bcfs.net).
